C. Spadaro
University of Catania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by C. Spadaro.
Psychopharmacology | 1979
Giovanna M. Scoto; C. Spadaro; S. Spampinato; R. Arrigo-Reina; S. Ferri
An enhanced prostaglandinlike activity is shown in homogenates of brain from rats treated intracerebroventricularly with 100 μg of metenkephalin. The increase is significantly reduced by naloxone pretreatment. A relationship is proposed between generation of prostaglandins in the brain following met-enkephalin administration and hyperthermic effect of the opiatelike factor in the rat. Normalization of prostaglandinlike activity following chronic administration of met-enkephalin in the rat may also account for the development of tolerance to its thermic effect.
Life Sciences | 1991
Giovanna M. Scoto; Carmela Parenti; Edmondo Scoto; C. Spadaro; R. Arrigo-Reina
Morphine and the synthetic opioid met-enkephalin analog [D-Ala2, MePhe4, Met(0)5ol] enkephalin (FK 33-824) injected intraperitoneally to rats at doses of 5-20 and 0.5-2 mg/kg respectively showed a protective effect on gastric lesion induced by cold-restraint stress. This protective effect was abolished by pretreatment with indomethacin. This suggests a role for prostaglandins in the protection, induced by opioids of the gastric mucosa against the development of stress-induced ulcers.
Pharmacological Research Communications | 1987
C. Spadaro; R. Arrigo-Reina; Giovanna M. Scoto
The effects of morphine HCl and a synthetic met-enkephalin analogue [D-Ala2,MePhe4,Met(O)5ol]enkephalin (FK 33-824) on gastric damage produced by the intraperitoneal administration of indomethacin (10 mg/kg i.p.) have been investigated. Rats intraperitoneally pretreated with morphine HCl (10 mg/kg i.p.) and FK 33-824 (1 mg/kg i.p.) showed a statistically significant reduction both of the number and intensity of lesions induced by indomethacin. This protection was reversed by naloxone HCl (2 mg/kg i.p.). The protective effect was not related to a reduction of gastric secretion since the antisecretory drug cimetidine (25 mg/kg i.p.) and methscopolamine bromide (10 mg/kg i.p.) did not significantly prevent mucosal damage under the same experimental conditions.
Archives of toxicology | 1979
Giovanna M. Scoto; C. Spadaro; S. Spampinato; N. Nossan; R. Arrigo-Reina; S. Ferri
The objective of the present study was to obtain information on prostaglandin (PG) biosynthesis in placenta following narcotic administration. PG biosynthetic capacity was determined in whole rat placenta homogenates in the presence of Na arachidonate, by evaluating net production of PGs assayed against PGE1 on rat stomach strips. An enhanced prostaglandin-like activity is shown in homogenates of placenta from rats treated subcutaneously with 10 mg/kg of morphine. This increase was prevented by naloxone pre-treatment. Continual morphine administration during gestation, results in a normalization of placental biosynthetic capacity thus suggesting the development of a tolerance to the narcotic effect.
Pharmacological Research | 1990
T. Catti; Carmela Parenti; C. Spadaro; R. Arrigo-Reina
The role of neural histamine in morphine-analgesia and in morphine-induced potentiation of stress analgesia was studied. Pretreatment of rats with α-fluoromethylhistidine (α-FMH) (200 μg i.c.v./rat; daily for five days) increased the analgesic potency of morphine, centrally or peripherally injected, in the tail-flick assay. This increase was significantly blocked by i.c.v. or i.p.β-funaltrexamine (β-FNA) a mu selective irreversible opioid receptor antagonist, whereas i.c.v injected naltrexone did not block the increased analgesic potency of the i.c.v. morphine. Rats subjected to cold-restrained stress (60 min at 4°C) showed increased tail-flick latency, compared to the unstressed group. The analgesic potency of morphine was significantly greater in rats subjected to restraint with respect to unstressed rats. However, the inhibition of histamine biosynthesis by α-FMH significantly reduced cold-restraint analgesia in controls, and also inhibited the analgesic efficacy of the opiate. These results indicate that neural histamine may be responsible for pain response modifications observed in rats subjected to cold-restraint conditions, and of morphine-potentiation of stress analgesia. The data also suggest a close association between increased analgesic potency of morphine and inhibition of histaminergic effects, possibly implying a functional supersensitivity and an increase in opioid receptors.
Pharmacological Research Communications | 1987
R. Arrigo-Reina; C. Spadaro
This study was designed to characterize physiological events related to a single or repeated experimental anaphylactoid reactions (by Compound 48/80) in non-stressed or cold-restrained rats. Acute treatment with Compound 48/80 (1 mg/kg, i.p.) increases Beta-endorphin(ir) content in the neurointermediate lobe (NIL) of rat pituitary. Moreover, repeated treatment with Compound 48/80 showed tolerance effects. These animals, exposed to stressful conditions, exhibited a fully evident paw oedema following carrageenin oedema-test, whereas saline-pretreated rats, under the same experimental conditions, showed reduced local inflammation. Since Compound 48/80 produces characteristic, systemic, anaphylactoid reaction in the rat, with a very high degree of selectivity in its action, our results suggest that mast-cell histamine and Beta-endorphin from NIL pituitary are involved in the bodys reactivity to stressful stimuli.
Psychopharmacology | 1980
C. Spadaro; Giovanna M. Scoto; P. Ferri; S. Ferri
An increase was found in the opiate activity of pituitary extracts obtained from rats injected with the neuroleptic drugs trifluoperazine and sulpiride. The increase of opiate activity, measured by bioassay, was particularly evident 2 h after the administration of sulpiride. Dexamethasone completely prevented the neuroleptic-induced effect. Trifluoperazine and sulpiride may have affected dopaminergic mechanisms regulating endorphin storage in the pituitary.
Opiate Receptors and the Neurochemical Correlates of Pain#R##N#Proceedings of the 3rd Congress of the Hungarian Pharmacological Society, Budapest, 1979 | 1980
R. Arrigo-Reina; S. Ferri; Giovanna M. Scoto; C. Spadaro; S. Spampinato; G. Costa
Naloxone, a specific blocker of opiate receptors, prevents the increase of plasma ACTH and corticosteroids in rats exposed to an audiogenic stress. It is suggested that endogenous opioid peptides operate, coordinately with pituitary hormones, in the adaptive response to stress.
Pharmacological Research | 1989
Carmela Parenti; G. Pagano; T. Catti; C. Spadaro; Giovanna M. Scoto
Pharmacological Research | 1995
R. Arrigo-Reina; Santina Chiechio; C. Spadaro